Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00459875
What this trial is testing

Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Large-scale testing (Phase 3)Study completedNCT03142334
What this trial is testing

Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 994
Not applicableStudy completedNCT01598597
What this trial is testing

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

Who this might be right for
Breast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more
Genentech, Inc. 276
Testing effectiveness (Phase 2)Study completedNCT00005027
What this trial is testing

Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Ended earlyNCT03927573
What this trial is testing

Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker

Who this might be right for
Non-small Cell Lung CancerProstate CancerRenal Cancer+1 more
AvenCell Europe GmbH 23
Testing effectiveness (Phase 2)Looking for participantsNCT06302569
What this trial is testing

Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma

Who this might be right for
Bellini CarcinomaCollecting Duct CarcinomaRenal Medullary Carcinoma
Giuseppe Procopio 23
Not applicableEnded earlyNCT00001803
What this trial is testing

Von Hippel-Lindau Disease Genetic Epidemiology Study

Who this might be right for
Von Hippel Lindau DiseaseKidney Neoplasms
National Cancer Institute (NCI) 546
Testing effectiveness (Phase 2)Study completedNCT02607553
What this trial is testing

Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA

Who this might be right for
Clear Cell Renal Cell Carcinoma
GenSpera, Inc. 2
Post-approval studies (Phase 4)Ended earlyNCT01486550
What this trial is testing

Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy

Who this might be right for
Kidney Cancer
Regional Hospital Holstebro 14
Not applicableStudy completedNCT06111560
What this trial is testing

Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Sun Yat-sen University 160
Early research (Phase 1)Study completedNCT03324373
What this trial is testing

Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Yousef Zakharia 11
Testing effectiveness (Phase 2)Ended earlyNCT02853162
What this trial is testing

Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)

Who this might be right for
Renal Cell Carcinoma
UMC Utrecht 30
Not applicableStudy completedNCT04342286
What this trial is testing

To Establish a Reproducible Organoid Culture Model With Human Kidney Cancer

Who this might be right for
Kidney Cancer
Chinese University of Hong Kong 20
Not applicableLooking for participantsNCT07704970
What this trial is testing

QLESP Block for Pain Control in Robotic Partial Nephrectomy

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Postoperative PainNerve Block
Huazhong University of Science and Technology 120
Testing effectiveness (Phase 2)UnknownNCT05024318
What this trial is testing

NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma, Clear Cell, Somatic
Peter MacCallum Cancer Centre, Australia 20
Early research (Phase 1)Study completedNCT00356460
What this trial is testing

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Who this might be right for
Carcinoma, Renal CellMelanoma
Genzyme, a Sanofi Company 29
Testing effectiveness (Phase 2)Study completedNCT00459979
What this trial is testing

Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT05931393
What this trial is testing

Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
RCCRenal Cell Carcinoma
University of Texas Southwestern Medical Center 18
Not applicableLooking for participantsNCT06278506
What this trial is testing

Resection or Ablation of Small Kidney Tumors

Who this might be right for
Kidney Cancer
Karolinska University Hospital 300
Next Page